Drug law enforcement efforts receive ample funding each year while drug treatment options remain shamefully underfunded. Many people who seek help for their problematic drug use are unable to access treatment, encountering insurance barriers, months-long wait lists, or programs that don't meet their needs. Far too many people are only able to access drug treatment as a result of an arrest or criminal conviction. DPA advocates expanding drug treatment access to meet need, as well as broadening the definition of drug treatment to include models of care that incorporate harm reduction principles and prioritize health, safety, and improving quality of life over strict abstinence. We are changing the national dialogue around treatment by raising awareness about proven drug treatment models, like heroin assisted treatment, that have been researched and employed successfully abroad but are still not available in the United States. Through these efforts, we are laying the foundation for more diverse and effective drug treatment options.
Harm reduction services and syringe exchange are more than just a prevention strategy. Access to these vital services enables HIV testing, linkage to care and other critical health/social services, as well as affirming the human rights and dignity of people who use drugs.
Advocates: Public Health Goals Are Positive, But Overreliance on Law Enforcement Destined to Fail
Obama Administration Urged to Take More Meaningful Steps to Treat Drug Use as a Health Issue
Washington, D.C. – The Obama Administration announced a new program today to fund “public health-public safety partnerships” to address the heroin and prescription opioid crisis. The new program would hire 15 drug intelligence officers and 15 health policy analysts to work within High Intensity Drug Trafficking Area (HIDTA) programs. The drug intelligence officers are expected to gather information on trafficking patterns and trends for street-level law enforcement.
Advocates Urge the Governor to Sign the Bill and Embrace Evidence-based, Public Health Approaches to Addressing Opioid Use and Overdose
Albany — Yesterday, the New York State Senate passed legislation supporting the use of medication assisted treatment in drug courts. The bill -- S.4239-B (Murphy) /A.6255-B (Rosenthal) -- passed the Assembly with overwhelming support last month.
On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development Committee. Nadelmann also submitted complementary written testimony. SB275 would create a four-year heroin-assisted treatment pilot program—the first in the United States. Heroin-assisted treatment is a feasible, effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs have failed.
International Experts to Testify on Incontrovertible Scientific Evidence Demonstrating Heroin-assisted Treatment is a Feasible, Proven, and Cost-Effective Intervention
Today, the Nevada State Senate will hold the first-ever legislative hearing on heroin-assisted treatment. Senate Bill 275, which would establish a four-year pilot program, will be heard in the Revenue and Economic Development Committee at 3:30 p.m. today.
Heroin-assisted treatment, also known as heroin maintenance, is an effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs, like residential rehabilitation or methadone, have failed.
Senate Bill 275 Would Create a Four-year Pilot Program
Heroin-assisted Treatment Programs Have Proven Successful in Reducing Overdoses, Disease and Crime in Numerous Countries, Including Germany, UK, Spain, Canada and more
Last week, Nevada State Senator Richard Segerblom introduced groundbreaking legislation, Senate Bill 275, which creates a four-year heroin-assisted treatment pilot project.
Heroin-assisted treatment, also known as heroin maintenance, refers to the supervised administration by a doctor of pharmaceutical-grade heroin (diacetylmorphine) to a small group of chronic heroin users who have failed more traditional forms of treatment including abstinence-based models and medication such as methadone.
Members of the Affected Community, International Experts, Treatment Providers, State Leaders and Physicians Gather to Discuss Opioid Use, Harm Reduction Strategies, Overdose Prevention, Supervised Injection Facilities, Heroin Assisted Treatment and Best Practices From Around the World
Daylong Symposium to be Held at Denver’s History Colorado Center, Thursday, March 5, 8:30 a.m. – 4:30 p.m.
Denver, CO – The Drug Policy Alliance, Harm Reduction Action Center and the Center for Public Health Practice will convene stakeholders to deliberate on the current impact of opioids and more effective responses to opioid use and dependency in Colorado. The Opioid Symposium is a daylong event on Thursday, March 5th at the History Colorado Center in Denver.
Global Commission on Drug Policy
This report reflects a new evolution in the thinking of the Global Commission, which includes Kofi Annan, Richard Branson, and the former presidents of Brazil, Chile, Colombia, Mexico, Poland, Portugal and Switzerland. They not only reiterate their demands for decriminalization, alternatives to incarceration, and greater emphasis on public health approaches – but now also call for responsible legal regulation of currently-illegal drugs.
DPA opposes efforts to criminalize and incarcerate people simply for using or possessing prescription drugs for non-medical purposes. Instead, we recommend policies that deal with prescription drug use and misuse from a health-oriented perspective.